Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification

被引:1
作者
Bae, Bong Kyung [1 ]
Cho, Won Kyung [1 ]
Kim, Byoung-Gie [2 ]
Choi, Chel Hun [2 ]
Kim, Tae-Joong [2 ]
Lee, Yoo-Young [2 ]
Lee, Jeong-Won [2 ]
Park, Won [1 ]
机构
[1] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
关键词
Adenocarcinoma; Pathology; PELVIC RADIATION-THERAPY; RADICAL HYSTERECTOMY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; UTERINE CERVIX; CARCINOMA; CANCER; CLASSIFICATION; INVASION;
D O I
10.1136/ijgc-2022-003971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCervical adenocarcinoma has poorer outcomes compared with squamous cell carcinoma; however, treatment is identical irrespective of histologic sub-types. This study aimed to investigate the patterns and risk factors of recurrence following surgery alone for low-risk early-stage cervical adenocarcinoma. MethodsWe retrospectively reviewed patients who underwent surgery alone for low-risk early-stage cervical adenocarcinoma between January 2001 and December 2018 in a single institution. Baseline clinicopathological characteristics were collected to identify the factors associated with recurrence-free survival. ResultsA total of 252 patients met the inclusion criteria. Most patients underwent radical hysterectomy (218 patients, 86.5%) and had usual type endocervical adenocarcinoma (190 patients, 75.4%). The International Federation of Gynecology and Obstetrics 2018 stage was IA1 in 72 patients (27.4%), IA2 in 58 (22.1%), IB1 in 51 (19.4%), and IB2 in 71 patients (27.0%). With a median follow-up of 70.4 months (range 6.2-252.5 months), 5-year survival rates were as follows: locoregional recurrence-free survival, 93.0%; recurrence-free survival, 89.6%; overall survival, 94.7%. The recurrence patterns were local in nine patients (32.1%), regional in five patients (17.8%), distant in 10 patients (35.7%), local and distant in one patient (3.6%), regional and distant in two patients (7.2%), and locoregional and distant in one patient (3.6%). In multivariable analysis, negative human papillomavirus (HPV) status (HR 7.314; p<0.001) and deep cervical stromal invasion (HR 5.110; p=0.003) were associated with poor locoregional recurrence-free survival. Patients were stratified based on the number of risk factors and a statistically significant difference in locoregional recurrence-free survival was observed: 5-year survival rates of 99.0%, 84.2%, and 50.0% for patients with 0, 1, and 2 risk factors (0 vs 1, p=0.001; 1 vs 2, p=0.011). ConclusionSurgery alone for low-risk early-stage cervical adenocarcinoma was associated with favorable outcomes over a long follow-up period. Patients with the highest risk of recurrence were those with a negative HPV status and deep cervical stromal invasion. Additional management following surgery may be considered in patients with these risk factors.
引用
收藏
页码:1524 / 1530
页数:7
相关论文
共 50 条
  • [31] Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 117 (01) : 53 - 58
  • [32] Risk stratification for recurrence in patients with esophageal and junctional carcinoma treated with neoadjuvant chemotherapy and surgery
    Dixit, S.
    Tilston, M.
    Peter, W. M.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (02) : 242 - 248
  • [33] Lymphadenectomy Alone Is a Feasible Option in Managing Incidentally-detected Early-stage Cervical Cancer After Simple Hysterectomy without Intermediate-risk Factors: An Application of the Concept of Less Radical Surgery
    Jeon, Hye Won
    Suh, Dong Hoon
    Kim, Kidong
    No, Jae Hong
    Kim, Yong-Beom
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 5135 - 5141
  • [34] Survival outcomes of minimally invasive versus open radical hysterectomy for low-risk, early-stage cervical cancer
    Summers, Garth
    Tierney, Brent
    Crotzer, David
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (03) : 380 - 381
  • [35] Risk Factors for Recurrence after Robot-Assisted Radical Hysterectomy for Early-Stage Cervical Cancer: A Multicenter Retrospective Study
    Ponce, Jordi
    Fernandez-Gonzalez, Sergi
    Gil-Moreno, Antonio
    Coronado, Pluvio J.
    De la Rosa, Jesus
    Nabais, Henrique
    Hernandez, Gines
    Taltavull, Anna
    Gilabert-Estelles, Juan
    Martinez-Roman, Sergio
    Barahona, Manel
    Barahona, Marc
    Martinez-Maestre, Maria Angeles
    [J]. CANCERS, 2020, 12 (11) : 1 - 11
  • [36] Establishment of a Novel Risk Stratification System Integrating Clinical and Pathological Parameters for Prognostication and Clinical Decision-Making in Early-Stage Cervical Cancer
    Wu, Haiying
    Huang, Lin
    Chen, Xiangtong
    Ouyang, Yi
    Li, Junyun
    Chen, Kai
    Huang, Xiaodan
    Chen, Foping
    Cao, Xinping
    [J]. CANCER MEDICINE, 2024, 13 (22):
  • [37] Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer
    Nishimura, Hiroki
    Amano, Tsukuru
    Yoneoka, Yutaka
    Tsuji, Shunichiro
    Taga, Yukiko
    Aki, Megumi
    Uno, Masaya
    Moritani, Suzuko
    Murakami, Ryusuke
    Kato, Tomoyasu
    Murakami, Takashi
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)
  • [38] Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer
    Matsuo, Koji
    Shimada, Muneaki
    Matsuzaki, Shinya
    Machida, Hiroko
    Shigeta, Shogo
    Yoshida, Hiroshi
    Kato, Kazuyoshi
    Kanao, Hiroyuki
    Takekuma, Munetaka
    Mikami, Mikio
    Okamoto, Aiko
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (09) : 1349 - 1358
  • [39] Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma
    Kwok, Wang Chun
    Ma, Ting Fung
    Ho, James Chung Man
    Lam, David Chi Leung
    Sit, Ko Yung
    Ip, Mary Sau Man
    Au, Timmy Wing Kuk
    Tam, Terence Chi Chun
    [J]. RESPIROLOGY, 2023, 28 (07) : 669 - 676
  • [40] A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma
    Jones, Gregory D.
    Brandt, Whitney S.
    Shen, Ronglai
    Sanchez-Vega, Francisco
    Tan, Kay See
    Martin, Axel
    Zhou, Jian
    Berger, Michael
    Solit, David B.
    Schultz, Nikolaus
    Rizvi, Hira
    Liu, Yuan
    Adamski, Ariana
    Chaft, Jamie E.
    Riely, Gregory J.
    Rocco, Gaetano
    Bott, Matthew J.
    Molena, Daniela
    Ladanyi, Marc
    Travis, William D.
    Rekhtman, Natasha
    Park, Bernard J.
    Adusumilli, Prasad S.
    Lyden, David
    Imielinski, Marcin
    Mayo, Marty W.
    Li, Bob T.
    Jones, David R.
    [J]. JAMA SURGERY, 2021, 156 (02)